19.1 C
Delhi
Tuesday, November 5, 2024

Torrent Pharma receives EIR from US FDA for Dahej facility

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Pharma major, Torrent pharma on Thursday said the US drug regulator US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for the company’s manufacturing facility at Dahej, Gujarat, and that the inspection has now been successfully closed by the US FDA.

Based on the March 2019 Inspection outcome, the Dahej facility was placed under “Official Action Indicated (OAI)” by the US FDA. The drug regulator had conducted re-inspection of the site in May 2023 from May 17, 23 to May 25, 23 and issued Form 483 with 2 observations.

The updated classification of site is VAI (voluntary action indicated) which indicates that Torrent will start to get approval of filed ANDAs. This will further enhance the company’s prospects and foster growth in the US market with its new product offerings.

The Dahej facility manufactures APIs and formulations for Torrent Pharma’s international markets.

Related articles

Telangana Govt to establish Spl Commission for BC reservations in local body elections

Hyderabad: The Telangana Government has decided to establish a special commission to address legal issues surrounding Backward Class...

Almora accident: Death toll reaches 28, CM expresses grief

Almora/Nainital: At least 28 passengers were killed and others are feared trapped after a bus fell into a...

Aspiration of the people remain strong for restoration of statehood to Jammu and Kashmir: LG

Srinagar: Lieutenant Governor Manoj Sinha on Monday said the aspiration of the people remains strong for the restoration...

Factory activities pick up in Oct, India manufacturing PMI rises to 57.5

New Delhi: On the back of new orders, India's factory activities accelerated in the month of October this...